BARÁK, Martin, Veronika FEDOROVÁ, Veronika POSPÍŠILOVÁ, Jan RAŠKA, Simona VOCHYÁNOVÁ, Jiří SEDMÍK, Hana HŘÍBKOVÁ, Hana KLÍMOVÁ, Tereza VÁŇOVÁ and Dáša BOHAČIAKOVÁ. Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids. Stem Cell Reviews and Reports. NEW YORK: SPRINGER, 2022, vol. 18, No 2, p. 792-820. ISSN 2629-3269. Available from: https://dx.doi.org/10.1007/s12015-021-10254-3.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids
Authors BARÁK, Martin (203 Czech Republic, belonging to the institution), Veronika FEDOROVÁ (203 Czech Republic, belonging to the institution), Veronika POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution), Jan RAŠKA (203 Czech Republic, belonging to the institution), Simona VOCHYÁNOVÁ (203 Czech Republic, belonging to the institution), Jiří SEDMÍK (203 Czech Republic, belonging to the institution), Hana HŘÍBKOVÁ (203 Czech Republic, belonging to the institution), Hana KLÍMOVÁ (203 Czech Republic, belonging to the institution), Tereza VÁŇOVÁ (203 Czech Republic, belonging to the institution) and Dáša BOHAČIAKOVÁ (703 Slovakia, guarantor, belonging to the institution).
Edition Stem Cell Reviews and Reports, NEW YORK, SPRINGER, 2022, 2629-3269.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.800
RIV identification code RIV/00216224:14110/22:00125401
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s12015-021-10254-3
UT WoS 000749958800002
Keywords in English iPSCs; Neural differentiation; Alzheimer’s disease; In vitro differentiation; Neural stem cells; Neural progenitors; Neurons; Astrocytes; Microglia; Cerebral organoids
Tags 14110517
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 20/2/2023 10:44.
Abstract
During the past two decades, induced pluripotent stem cells (iPSCs) have been widely used to study mechanisms of human neural development, disease modeling, and drug discovery in vitro. Especially in the field of Alzheimer’s disease (AD), where this treatment is lacking, tremendous effort has been put into the investigation of molecular mechanisms behind this disease using induced pluripotent stem cell-based models. Numerous of these studies have found either novel regulatory mechanisms that could be exploited to develop relevant drugs for AD treatment or have already tested small molecules on in vitro cultures, directly demonstrating their effect on amelioration of AD-associated pathology. This review thus summarizes currently used differentiation strategies of induced pluripotent stem cells towards neuronal and glial cell types and cerebral organoids and their utilization in modeling AD and potential drug discovery.
Links
GA21-21510S, research and development projectName: Studium molekulárních mechanismů vzniku Alzheimerovy choroby pomocí cerebrálních organoidů (Acronym: AD Brain Organoids)
Investor: Czech Science Foundation
GJ18-25429Y, research and development projectName: Funkční studie mikroRNA u nerálních kmenových buněk v průběhu diferenciace
Investor: Czech Science Foundation
MUNI/A/1382/2019, interní kód MUName: Zdroje pro tkáňové inženýrství 10 (Acronym: TissueEng 10)
Investor: Masaryk University, Category A
MUNI/A/1398/2021, interní kód MUName: Zdroje pro tkáňové inženýrství 12 (Acronym: TissueEng 12)
Investor: Masaryk University
MUNI/A/1418/2021, interní kód MUName: Biomedicínské vědy II (Acronym: BIOMED)
Investor: Masaryk University
MUNI/G/1131/2017, interní kód MUName: Transformative stem cell-based model of Alzheimer’s disease and advanced analytics to study the role of membrane lipids in the pathogenesis
Investor: Masaryk University, INTERDISCIPLINARY - Interdisciplinary research projects
MUNI/R/1697/2020, interní kód MUName: Career Restart - Stem Cell-Based Models of Neurodegeneration
Investor: Masaryk University, CAREER RESTART
MUNI/11/SUP/19/2020, interní kód MUName: Efekt buněčného stárnutí na vznik Alzheimerovy nemoci
Investor: Masaryk University
NU21-08-00373, research and development projectName: Patogeny indukovaná senescence jako spouštěcí faktor Alzheimerovy nemoci (Acronym: Patogeny u AD)
Investor: Ministry of Health of the CR, Subprogram 1 - standard
NV19-08-00472, research and development projectName: Klinicky relevantní biochemické, imunologické a buněčné biomarkery Alzheimerovy nemoci a stárnutí (Acronym: BioMAD)
Investor: Ministry of Health of the CR
8F20009, research and development projectName: Identifying and treating SORL1-associated Alzheimer’s disease (Acronym: SORLA - FIX)
Investor: Ministry of Education, Youth and Sports of the CR, Neurodegenerative Disease (JPND)
PrintDisplayed: 16/7/2024 23:21